Holen Sie sich die Stockscreener-App
8.02
1.23%
-0.10
Handel nachbörslich:
8.10
0.08
+1.00%
Schlusskurs vom Vortag:
$8.12
Offen:
$8.11
24-Stunden-Volumen:
111.29K
Relative Volume:
0.38
Marktkapitalisierung:
$128.24M
Einnahmen:
$5.12M
Nettoeinkommen (Verlust:
$-67.00M
KGV:
-5.4558
EPS:
-1.47
Netto-Cashflow:
$-38.94M
1W Leistung:
-3.49%
1M Leistung:
-1.11%
6M Leistung:
-6.95%
1J Leistung:
+14.62%
1-Tages-Spanne:
$7.92
$8.30
1-Wochen-Bereich:
$7.90
$8.95
52-Wochen-Spanne:
$3.28
$9.8212
Verrica Pharmaceuticals Inc Stock (VRCA) Company Profile
Firmenname
Verrica Pharmaceuticals Inc
Sektor
Branche
Telefon
484-453-3300
Adresse
10 NORTH HIGH STREET, WEST CHESTER, PA
Vergleichen Sie VRCA mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
VRCA
Verrica Pharmaceuticals Inc
|
8.02 | 129.84M | 5.12M | -67.00M | -38.94M | -1.47 |
|
VRTX
Vertex Pharmaceuticals Inc
|
469.68 | 122.84B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
801.01 | 85.37B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
399.40 | 55.82B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
795.57 | 50.67B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
170.27 | 37.54B | 447.02M | -1.18B | -906.14M | -6.1812 |
Verrica Pharmaceuticals Inc Stock (VRCA) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2024-11-06 | Herabstufung | H.C. Wainwright | Buy → Neutral |
| 2024-11-05 | Herabstufung | RBC Capital Mkts | Outperform → Sector Perform |
| 2023-07-25 | Hochstufung | Needham | Hold → Buy |
| 2023-03-22 | Eingeleitet | Jefferies | Buy |
| 2023-02-13 | Hochstufung | RBC Capital Mkts | Sector Perform → Outperform |
| 2022-05-25 | Herabstufung | RBC Capital Mkts | Outperform → Sector Perform |
| 2021-05-14 | Eingeleitet | RBC Capital Mkts | Outperform |
| 2020-12-24 | Bestätigt | H.C. Wainwright | Buy |
| 2020-07-15 | Herabstufung | BofA Securities | Buy → Neutral |
| 2020-06-30 | Bestätigt | H.C. Wainwright | Buy |
| 2020-06-24 | Eingeleitet | Northland Capital | Outperform |
| 2020-03-24 | Eingeleitet | Needham | Buy |
| 2019-02-21 | Eingeleitet | H.C. Wainwright | Buy |
Alle ansehen
Verrica Pharmaceuticals Inc Aktie (VRCA) Neueste Nachrichten
Will Verrica Pharmaceuticals Inc. (1NE) stock outperform benchmarks2025 Major Catalysts & Accurate Trade Setup Notifications - ulpravda.ru
Verrica doses first patient in phase 3 trial for common wart treatment - Investing.com Nigeria
First Patient Dosed in Phase 3 VP-102 Common Warts Program - Dermatology Times
Verrica Pharmaceuticals stock advances as TD Cowen reiterates Buy rating By Investing.com - Investing.com Nigeria
Verrica Pharmaceuticals stock advances as TD Cowen reiterates Buy rating - Investing.com
Verrica Pharmaceuticals announces first patient dosed in phase 3 program - MarketScreener
Verrica Pharmaceuticals (VRCA) Begins Phase 3 Trials for Common Warts Treatment - GuruFocus
Verrica Pharmaceuticals Announces First Patient Dosed in - GlobeNewswire
Verrica Pharmaceuticals Inc. (NASDAQ:VRCA) Short Interest Update - Defense World
Short Interest in Verrica Pharmaceuticals Inc. (NASDAQ:VRCA) Decreases By 26.2% - MarketBeat
Verrica Pharmaceuticals appoints Charles Frantzreb to board and approves equity grants - Investing.com Canada
Verrica Pharmaceuticals appoints Charles Frantzreb to board and approves equity grants By Investing.com - Investing.com South Africa
Verrica Pharmaceuticals Adds Caligan Partner to Board - TipRanks
Verrica Pharmaceuticals Appoints New Director - TradingView — Track All Markets
Verrica Pharmaceuticals Inc. Appoints Charles Frantzreb as Director, Effective December 26, 2025 - MarketScreener
Can Verrica Pharmaceuticals Inc. stock reach $100 price targetHigh Yield Income Stocks & Low Cost Portfolio Tips - bollywoodhelpline.com
Verrica Pharmaceuticals (VRCA) Stock Price, Quote, News & History - Benzinga
Verrica Pharmaceuticals upgraded to buy from hold at Brookline - MSN
Gains Report: Can Verrica Pharmaceuticals Inc. stock reach $100 price targetJuly 2025 Reactions & Entry Point Confirmation Signals - Улправда
Is Verrica Pharmaceuticals Inc. stock a safe buy before earningsTrade Analysis Report & AI Optimized Trading Strategy Guides - Улправда
Will Verrica Pharmaceuticals Inc. stock pay special dividendsQuarterly Performance Summary & AI Powered Market Entry Strategies - Улправда
Will Verrica Pharmaceuticals Inc. stock see insider buyingPortfolio Value Summary & Target Return Focused Stock Picks - Улправда
Can Verrica Pharmaceuticals Inc. stock surprise with earnings upsideJuly 2025 Outlook & Verified Swing Trading Watchlists - Улправда
Verrica Pharmaceuticals (FRA:1NE0) EV-to-OCF : -4.47 (As of Dec. 19, 2025) - GuruFocus
Can Verrica Pharmaceuticals Inc. stock weather global recessionJuly 2025 Chart Watch & Smart Investment Allocation Tips - Улправда
Why Verrica Pharmaceuticals Inc. stock is favored by top institutions2025 Volatility Report & High Accuracy Swing Trade Signals - bolumsonucanavari.com
Is Verrica Pharmaceuticals Inc. stock supported by innovation pipelineJuly 2025 Trade Ideas & High Accuracy Investment Entry Signals - Улправда
Is Verrica Pharmaceuticals Inc. stock a buy on dipsJuly 2025 Highlights & AI Powered Trade Plan Recommendations - Улправда
Will Verrica Pharmaceuticals Inc. (1NE) stock boost dividends furtherMarket Sentiment Review & Reliable Entry Point Alerts - DonanımHaber
Verrica Pharmaceuticals (NASDAQ:VRCA) Rating Increased to Buy at Brookline Capital Management - Defense World
Brookline Capital upgrades Verrica Pharmaceuticals (VRCA) - MSN
Aug Drivers: Will Verrica Pharmaceuticals Inc. stock see insider buyingMarket Sentiment Review & Weekly Top Gainers Alerts - Улправда
Is Verrica Pharmaceuticals Inc. (1NE) stock undervalued after correction2025 Sector Review & Verified Momentum Stock Alerts - Улправда
Verrica Pharmaceuticals (NASDAQ:VRCA) Stock Rating Upgraded by Brookline Capital Management - MarketBeat
Verrica Pharmaceuticals (VRCA) Receives Upgrade from Brookline C - GuruFocus
Verrica Pharmaceuticals stock upgraded to Buy by Brookline on pipeline potential - Investing.com Nigeria
Top Premarket Decliners - marketscreener.com
[S-3] Verrica Pharmaceuticals Inc. Shelf Registration Statement | VRCA SEC FilingForm S-3 - Stock Titan
Verrica Pharmaceuticals Earnings Notes - Trefis
Armistice Capital LLC Increases Stock Holdings in Verrica Pharmaceuticals Inc. $VRCA - Defense World
Verrica’s $50 Million PIPE Deal Sparks Big Questions About Its Next Growth Phase - MSN
Verrica Pharmaceuticals Inc. announced that it has received $50.067383 million in funding from BKB Growth Investments, LLC and other investors. - marketscreener.com
How buybacks impact Verrica Pharmaceuticals Inc. stock value2025 Investor Takeaways & Daily Stock Trend Watchlist - Newser
How Verrica Pharmaceuticals Inc. (1NE) stock performs during market turbulenceJuly 2025 Action & Real-Time Sentiment Analysis - Newser
Why Verrica Pharmaceuticals Inc. (1NE) stock appeals to dividend investorsTrade Risk Assessment & Reliable Price Action Trade Plans - Newser
Will Verrica Pharmaceuticals Inc. (1NE) stock extend growth storyJuly 2025 EndofMonth & Free Low Drawdown Momentum Trade Ideas - Newser
Will Verrica Pharmaceuticals Inc. (1NE) stock benefit from mergersJuly 2025 Review & Safe Capital Investment Plans - Newser
Why analysts recommend Verrica Pharmaceuticals Inc. (1NE) stockJuly 2025 Rallies & Long Hold Capital Preservation Plans - Newser
What market sentiment indicators show for Verrica Pharmaceuticals Inc. (1NE) stockJuly 2025 Price Swings & High Conviction Trade Alerts - Newser
Finanzdaten der Verrica Pharmaceuticals Inc-Aktie (VRCA)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.80%
4.56%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):